# Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy

> **NCT01265069** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 204 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** high dose dual therapy
- **DRUG:** concomitant therapy

## Key facts

- **NCT ID:** NCT01265069
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2013-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01265069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01265069, "Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01265069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*